Skip to main content

Fentanyl Patch News

FDA Medwatch Alert: Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System

January 31, 2025 – Morristown, NJ – Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is t...

Ask a question

To post your own question to our community, sign in or create an account.